Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novartis
Biotech
Ikena and Inmagene choose combined CEO—Chutes & Ladders
Ikena and Inmagene choose combined CEO. Galapagos expands executive island. Trogenix trots out new clinical leaders.
Darren Incorvaia
,
Zoey Becker
Jul 25, 2025 8:30am
Matchpoint nets $60M in new Novartis deal
Jul 24, 2025 12:04pm
Sarepta shakes up C-suite amid org overhaul—Chutes & Ladders
Jul 18, 2025 8:30am
Novartis' ianalumab fails to show promise in dermatology study
Jul 17, 2025 4:28am
Novartis inks $175M option deal for Sironax’s BBB tech
Jul 9, 2025 10:29am
Novartis pens ProFound pact for cardiovascular disease targets
Jun 26, 2025 6:30am
